More than 150 participants from 27 countries attended this year's SCHWIND User Meeting in Muscat, Oman.
Retinopathy of prematurity study demonstrates noninferiority of combination microdrops compared to standard mydriatics
The authors investigated systemic adverse events associated with commercial mydriatics administered during retinopathy of prematurity (ROP) screening
Higher Molar Dose and Its Translation into Clinical Practice
Conjunctival bacteria linked to higher fluoroquinolone resistance in new study from Brazil
Clinicians need to better understand how to reduce the growth of antibiotic-resistant, more virulent bacteria, the authors said
Oculis shares phase 2 ACUITY results for novel neuroprotective therapy OCS-05
Investigators reported that the trial demonstrated significant improvements in visual function and retinal structure for patients with optic neuritis
Regeneron acquires UK biotech company Oxular, broadening retina portfolio
In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular oedema
OCT and OCTA provide insights on neuroretinal changes associated with fibromyalgia
Patients with fibromyalgia experienced changes in the macular ganglion cell layer and retinal nerve fiber layer
